Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: Analysis of results in 140 surgically resected patients

被引:185
作者
Yoshiya Fujimoto
Yukihiro Nakanishi
Kimio Yoshimura
Tadakazu Shimoda
机构
[1] Clinical Laboratory Division, National Cancer Center Hospital, Tokyo 104-0045, 5-1-1 Tsukiji, Chuo-ku
[2] Pathology Division, Natl. Cancer Ctr. Research Institute, Tokyo
[3] Cancer Info./Epidemiology Division, Natl. Cancer Ctr. Research Institute, Tokyo
关键词
Clinicopathologic study; Malignant gastric GIST; Multivariate analysis Immunohistochemistry; Prognostic factor;
D O I
10.1007/s101200300005
中图分类号
学科分类号
摘要
Background. Malignant gastrointestinal stromal tumors (GISTs), previously termed leiomyosarcomas or epithelioid leiomyosarcomas, are known to show wide variability in their malignancy. We evaluated the clinicopathological features of a large number of primary malignant gastric GISTs to clarify which features were independent prognostic factors. Methods. Clinicopathologic features (age, sex, tumor location, mode of growth and size, surgical method, ulceration, cell type, nuclear atypia, cellularity, mitotic index, growth pattern, necrosis, hemorrhage, direct tumor invasion, peripheral lymphoid cuffing, expression of α-smooth muscle actin [α-SMA], desmin, caldesmon, vimentin, CD34, c-kit protein and S-100 protein, and MIB-1 index) were evaluated by multivariate analysis in 140 patients with resected primary malignant gastric GISTs to identify independent prognostic factors. Results. Univariate analysis showed that each of the following factors had a significant deleterious influence on prognosis: male sex, tumor size 10 cm or more, presence of ulceration, an epithelioid cell component, severe nuclear atypia, high cellularity, a mitotic index of more than 10, an exogastric or invasive growth pattern, necrosis, hemorrhage, direct tumor invasion of surrounding tissue, negative caldesmon immunoreactivity, positive S-100 protein immunoreactivity, and a MIB-1 antigen labeling index of more than 10%. Multivariate analysis showed that male sex, tumor size 10 cm or more, presence of an epithelioid cell component, and a mitotic index of more than 10 were statistically significant indicators of a poor prognosis (P = 0.013, 0.001, 0.014, and <0.001, respectively). Multivariate analysis using the MIB-1 index instead of a mitotic count showed that male sex, tumor size 10 cm or more, presence of necrosis, and a MIB-1 antigen labeling index of more than 10% were independent predictors of a poor prognosis (P = 0.009, 0.001, 0.043, and <0.001, respectively). Conclusion. Male sex, tumor size 10 cm or more, and cell proliferation as estimated by the mitotic index or MIB-1 index are independent indicators of a poor prognosis in primary malignant gastric GIST.
引用
收藏
页码:39 / 48
页数:9
相关论文
共 26 条
[1]  
Miettinen M., Blay J.Y., Sobin L.H., Mesenchymal Tumors of the Stomach. WHO Classification of Tumors of the Digestive System, pp. 62-65, (1999)
[2]  
Kindblom L.G., Remotti H.E., Aldenborg F., Meis-Kindblom J.M., Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the intestinal cells of Cajal, Am J Pathol, 152, pp. 1259-1269, (1998)
[3]  
Hirota S., Isozaki K., Moriyama Y., Hashimoto K., Nishida T., Ishiguro S., Et al., Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors, Science, 279, pp. 577-580, (1998)
[4]  
Newman P.L., Wadden C., Fletcher C.D.M., Gastrointestinal stromal tumors: Correlation of immunophenotype with clinicopathological features, J Pathol, 164, pp. 107-117, (1991)
[5]  
Erlandson R.A., Klimstra D.S., Woodruff J.M., Subclassification of gastrointestinal stromal tumors based on evaluation by electron microscopy and immunohistochemistry, Ultrastruct Pathol, 20, pp. 373-393, (1996)
[6]  
Sarlomo-Rikala M., Kovatich A., Barusevicius A., Miettinen M., CD117: A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34, Mod Pathol, 11, pp. 728-734, (1998)
[7]  
Miettinen M., Virolainen M., Maarit S.R., Gastrointestinal stromal tumors - Value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas, Am J Surg Pathol, 19, pp. 207-216, (1995)
[8]  
Ueyama T., Guo K.J., Hashimoto H., Daimaru Y., Enjoji M., A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors, Cancer, 69, pp. 947-955, (1992)
[9]  
Shiu M.H., Farr G.H., Papachristou D.N., Hajdu S.I., Myosarcomas of the stomach: Natural history, prognostic factors and management, Cancer, 49, pp. 177-187, (1982)
[10]  
Evans H.L., Smooth muscle tumors of the gastrointestinal tract: A study of 56 cases followed for a minimum of 10 years, Cancer, 56, pp. 2242-2250, (1985)